Lidocaine Hydrochloride
Who holds supplier records for Lidocaine Hydrochloride? 13 organisations hold a current record for Lidocaine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (3), Sweden (1), Taiwan (1) and 3 other countries (3).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lidocaine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lidocaine-hydrochloride
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lidocaine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Apex Healthcare LimitedIndiaCEPActive DMF 39139, 34307 · latest filing Dec 2023
- CAMBREX KARLSKOGA ABSwedenCEP Company GMP cert on recordActive DMF 19531 · latest filing Apr 2006
- DELTA SYNTHETIC CO LTDTaiwanCEPActive DMF 11338 · latest filing Feb 1995
- HARMAN FINOCHEM LTDIndiaCEP Company GMP cert on recordActive DMF 28784 · latest filing Oct 2014
- MOEHS IBERICA SLSpainCEPActive DMF 5876 · latest filing Jun 1985
- SWATI SPENTOSE PRIVATE LTDIndiaCEPActive DMF 25963 · latest filing Mar 2012
- MAHENDRA CHEMICALSIndiaActive DMF 24051 · latest filing Aug 2010
- SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTDChinaActive DMF 40814 · latest filing Nov 2024
- W R GRACE AND CO -CONNUnited StatesCEPActive DMF 4323 · latest filing Nov 1981
- Chemino Pharma LtdIndiaCEP
- ChinaCEP
- ItalyCEP Company GMP cert on record
- Viwit Pharmaceutical Co., Ltd.ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (11)
Certificates of Suitability on the EDQM register for Lidocaine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou | CN | CEP 2024-340 - Rev 01 Lidocaine hydrochloride monohydrate | Sept 2026 | — |
| APEX HEALTHCARE LIMITED Ankleshwar | IN | CEP 2024-258 - Rev 00 Lidocaine hydrochloride monohydrate | Oct 2025 | — |
| HARMAN FINOCHEM LIMITED Mumbai | IN | CEP 2015-044 - Rev 01 Lidocaine hydrochloride monohydrate | Apr 2025 | — |
| CHEMINO PHARMA LIMITED Mumbai | IN | CEP 2021-084 - Rev 01 Lidocaine hydrochloride monohydrate | Apr 2025 | — |
| SWATI SPENTOSE PVT. LTD. Mumbai | IN | CEP 2013-103 - Rev 04 Lidocaine hydrochloride monohydrate | Feb 2025 | — |
| VIWIT PHARMACEUTICAL CO. LTD Tengzhou | CN | CEP 2022-431 - Rev 00 Lidocaine hydrochloride monohydrate | Sept 2024 | — |
| Moehs Iberica S.L. Rubi | ES | CEP 1996-020 - Rev 09 Lidocaine hydrochloride monohydrate | May 2024 | — |
| SOCIETÀ ITALIANA MEDICINALI SCANDICCI S.I.M.S. S.R.L Reggello | IT | CEP 2001-014 - Rev 04 Lidocaine hydrochloride monohydrate | Sept 2023 | Inspected Nov 2024 Italy |
| W. R. GRACE & CO.-CONN. Columbia | US | R1-CEP 2010-029 - Rev 02 Lidocaine hydrochloride monohydrate | Aug 2021 | — |
| CAMBREX KARLSKOGA AB Karlskoga | SE | R1-CEP 2011-325 - Rev 02 Lidocaine hydrochloride monohydrate | Jun 2021 | — |
| DELTA SYNTHETIC CO., LTD. New Taipei City | TW | R1-CEP 2013-198 - Rev 00 Lidocaine hydrochloride monohydrate | Nov 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Lidocaine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- KONDUSKAR LABORATORIES PVT LTDInactive DMF 24056 · filed Aug 2010
- GUFIC BIOSCIENCES LTDInactive DMF 17483 · filed Jun 2004
- NAPP CHEMICALS INCInactive DMF 4182 · filed Jun 1981
- SANOFI PHARMACEUTICALS INCInactive DMF 2801 · filed Nov 1976
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Lidocaine Hydrochloride is a local anesthetic and antiarrhythmic drug used to numb tissue in a specific area and to treat ventricular arrhythmias. It works by blocking sodium channels, which inhibits nerve impulse initiation and conduction.
Chemical identity
- IUPAC name
- [2-(2,6-dimethylanilino)-2-oxoethyl]-diethylazanium;chloride;hydrate
- Canonical SMILES
- CC[NH+](CC)CC(=O)NC1=C(C=CC=C1C)C.O.[Cl-]
- InChIKey
- YECIFGHRMFEPJK-UHFFFAOYSA-N
- Synonyms
- Xylocaine API, akten, alphacaine hydrochloride, anestacon, hbn-1 component lidocaine hydrochloride, laryng-o-jet kit, laryngotracheal anesthesia kit, lidocaine hcl, lidocaine hydrochloride monohydrate, lidocaine hydrochloride usp, lidocaini hydrochloridum, lidocaton
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
- Physiologic effect
- Local Anesthesia
- Chemical structure
- Amides
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lidocaine Hydrochloride?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Lidocaine Hydrochloride: Apex Healthcare Limited (India), CAMBREX KARLSKOGA AB (Sweden), DELTA SYNTHETIC CO LTD (Taiwan), HARMAN FINOCHEM LTD (India), MOEHS IBERICA SL (Spain), SWATI SPENTOSE PRIVATE LTD (India), MAHENDRA CHEMICALS (India) and SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (China), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lidocaine Hydrochloride Drug Master Files are active?
Apex Healthcare Limited (DMF 39139, 34307), CAMBREX KARLSKOGA AB (DMF 19531), DELTA SYNTHETIC CO LTD (DMF 11338), HARMAN FINOCHEM LTD (DMF 28784), MOEHS IBERICA SL (DMF 5876), SWATI SPENTOSE PRIVATE LTD (DMF 25963), MAHENDRA CHEMICALS (DMF 24051) and SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (DMF 40814) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lidocaine Hydrochloride records mean?
4 organisations have only inactive Type II DMFs for Lidocaine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Lidocaine Hydrochloride have a European Certificate of Suitability?
Yes. 11 organisations hold a valid CEP for Lidocaine Hydrochloride on the EDQM register, including SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou (CN), APEX HEALTHCARE LIMITED Ankleshwar (IN), HARMAN FINOCHEM LIMITED Mumbai (IN), CHEMINO PHARMA LIMITED Mumbai (IN), SWATI SPENTOSE PVT. LTD. Mumbai (IN) and VIWIT PHARMACEUTICAL CO. LTD Tengzhou (CN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Lidocaine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lidocaine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.